BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26662650)

  • 1. Association between omentin-1, bone metabolism markers, and cytokines of the RANKL/RANK/OPG system in girls with anorexia nervosa.
    Gołąbek K; Ostrowska Z; Ziora K; Oświęcimska J; Świętochowska E; Marek B; Kajdaniuk D; Strzelczyk J; Kos-Kudła B
    Endokrynol Pol; 2015; 66(6):514-20. PubMed ID: 26662650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selected pro-inflammatory cytokines, bone metabolism, osteoprotegerin, and receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa.
    Ostrowska Z; Ziora K; Oświęcimska J; Marek B; Świętochowska E; Kajdaniuk D; Strzelczyk J; Cieślicka A; Wołkowska-Pokrywa K; Kos-Kudła B
    Endokrynol Pol; 2015; 66(4):313-21. PubMed ID: 26323468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaspin and selected indices of bone status in girls with anorexia nervosa.
    Ostrowska Z; Ziora K; Oświęcimska J; Świętochowska E; Marek B; Kajdaniuk D; Strzelczyk J; Gołąbek K; Morawiecka-Pietrzak M; Wołkowska-Pokrywa K; Kos-Kudła B
    Endokrynol Pol; 2016; 67(6):599-606. PubMed ID: 28042653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β1, bone metabolism, osteoprotegerin, and soluble receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa.
    Ostrowska Z; Ziora K; Oświęcimska J; Świętochowska E; Marek B; Kajdaniuk D; Strzelczyk J; Gołąbek K; Wołkowska-Pokrywa K; Kos-Kudła B
    Endokrynol Pol; 2016; 67(5):493-500. PubMed ID: 27828689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RANKL/RANK/OPG system and bone status in females with anorexia nervosa.
    Ostrowska Z; Ziora K; Oświęcimska J; Swiętochowska E; Szapska B; Wołkowska-Pokrywa K; Dyduch A
    Bone; 2012 Jan; 50(1):156-60. PubMed ID: 22001124
    [TBL] [Abstract][Full Text] [Related]  

  • 6.  Dehydroepiandrosterone sulfate, osteoprotegerin and its soluble ligand sRANKL and bone metabolism in girls with anorexia nervosa.
    Ostrowska Z; Ziora K; Oświęcimska J; Swiętochowska E; Wołkowska-Pokrywa K
    Postepy Hig Med Dosw (Online); 2012 Sep; 66():655-62. PubMed ID: 23001207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone metabolism, osteoprotegerin, receptor activator of nuclear factor-κB ligand and selected adipose tissue hormones in girls with anorexia nervosa.
    Ostrowska Z; Ziora K; Oświęcimska J; Świętochowska E; Marek B; Kajdaniuk D; Wołkowska-Pokrywa K; Kos-Kudła B
    Endokrynol Pol; 2014; 65(1):33-9. PubMed ID: 24549600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin, the RANKL/RANK/OPG system, and bone metabolism in girls with anorexia nervosa.
    Ostrowska Z; Ziora K; Kos-Kudła B; Swietochowska E; Oświecimska J; Dyduch A; Wołkowska-Pokrywa K; Szapska B
    Endokrynol Pol; 2010; 61(1):117-23. PubMed ID: 20205114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between chemerin, bone metabolism, the RANKL/RANK/OPG system, and bone mineral density in girls with anorexia nervosa.
    Ostrowska Z; Morawiecka-Pietrzak M; Pluskiewicz W; Świętochowska E; Strzelczyk J; Gołąbek K; Gaździcka J; Ziora K
    Endokrynol Pol; 2022; 73(1):26-34. PubMed ID: 35119086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selected adipose tissue hormones, bone metabolism, osteoprotegerin and receptor activator of nuclear factor-kB ligand in postmenopausal obese women.
    Ostrowska Z; Świętochowska E; Marek B; Kajdaniuk D; Tyrpień-Golder K; Wołkowska-Pokrywa K; Damasiewicz-Bodzek A; Kos-Kudła B
    Endokrynol Pol; 2014; 65(6):438-48. PubMed ID: 25554611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the relationship between melatonin, hormones of the pituitary-ovarian, -thyroid and -adrenocortical axes, and osteoprotegerin and its ligand sRANKL in girls with anorexia nervosa.
    Ostrowska Z; Ziora K; Oświęcimska J; Wołkowska-Pokrywa K; Szapska B
    Postepy Hig Med Dosw (Online); 2013 May; 67():433-41. PubMed ID: 23752595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian concentrations of free testosterone, selected markers of bone metabolism, osteoprotegerin and its ligand sRANKL in obese postmenopausal women.
    Ostrowska Z; Kos-Kudła B; Marek B; Kajdaniuk D; Wołkowska-Pokrywa K
    Postepy Hig Med Dosw (Online); 2011 Oct; 65():658-67. PubMed ID: 22100799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between serum omentin-1 level and bone mineral density in girls with anorexia nervosa.
    Guo LJ; Jiang TJ; Liao L; Liu H; He HB
    J Endocrinol Invest; 2013 Mar; 36(3):190-4. PubMed ID: 22714099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis.
    Dovio A; Generali D; Tampellini M; Berruti A; Tedoldi S; Torta M; Bonardi S; Tucci M; Allevi G; Aguggini S; Bottini A; Dogliotti L; Angeli A
    Osteoporos Int; 2008 Jan; 19(1):113-7. PubMed ID: 17703272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum omentin levels in adolescent girls with anorexia nervosa and obesity.
    Oświęcimska J; Suwała A; Świętochowska E; Ostrowska Z; Gorczyca P; Ziora-Jakutowicz K; Machura E; Szczepańska M; Kukla M; Stojewska M; Ziora D; Ziora K
    Physiol Res; 2015; 64(5):701-9. PubMed ID: 25804090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omentin-1 exerts bone-sparing effect in ovariectomized mice.
    Xie H; Xie PL; Luo XH; Wu XP; Zhou HD; Tang SY; Liao EY
    Osteoporos Int; 2012 Apr; 23(4):1425-36. PubMed ID: 21755404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton.
    Mountzios G; Dimopoulos MA; Bamias A; Papadopoulos G; Kastritis E; Syrigos K; Pavlakis G; Terpos E
    Acta Oncol; 2007; 46(2):221-9. PubMed ID: 17453373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease.
    Doumouchtsis K; Perrea D; Doumouchtsis S; Tziamalis M; Poulakou M; Vlachos I; Kostakis A
    Ther Apher Dial; 2009 Feb; 13(1):49-55. PubMed ID: 19379170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. sRANKL/osteoprotegerin complex and biochemical markers in a cohort of male and female hemodialysis patients.
    Doumouchtsis KK; Kostakis AI; Doumouchtsis SK; Tziamalis MP; Tsigris C; Kostaki MA; Perrea DN
    J Endocrinol Invest; 2007 Oct; 30(9):762-6. PubMed ID: 17993768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of zinc supplementation against cadmium-induced oxidative stress and the RANK/RANKL/OPG system imbalance in the bone tissue of rats.
    Brzóska MM; Rogalska J
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):208-20. PubMed ID: 23726800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.